National Psoriasis Foundation

Recent papers from National Psoriasis Foundation

1. Understanding Social Drivers of Health Among US Adults with Psoriasis from Different Races and EthnicitiesDermatology and Therapy · 2026
2. The National Psoriasis Foundation Primer on GLP-1 Receptor Agonists in Psoriasis: A Review.2026
3. Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque PsoriasisJAMA Dermatology · 2026
4. Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitorsJournal of the American Academy of Dermatology · 2025
5. Patient Experiences with Psoriatic Disease in the USA: Results from the Psoriasis and Beyond Global StudyDrugs - Real World Outcomes · 2025
6. Patient-Identified Treatment Goals for Psoriatic Disease: Results From a US Patient SurveyJournal of Psoriasis and Psoriatic Arthritis · 2024
7. Tackling Multiple Biologic Failure in Psoriasis: Research and Advocacy PerspectivesJournal of Psoriasis and Psoriatic Arthritis · 2024
8. Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With PsoriasisJAMA Dermatology · 2024
9. Identifying Core Outcome Domains in Chronic Skin Disease Using the Best-Worst Scaling MethodJAMA Dermatology · 2024
10. Association Between Poor Sleep and Myocardial Infarction in Patients with Psoriasis: Findings from a Cross-Sectional Study with the National Psoriasis FoundationDermatology and Therapy · 2023
11. Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasis registryJournal of the American Academy of Dermatology · 2023
12. National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicineJAAD International · 2023
13. Understanding potential participation barriers to improve trial design and outcomes: clinical trial simulation in palmoplantar pustulosis as a case studyBMJ Open · 2023
14. Psoriasis Involving Special Areas is Associated with Worse Quality of Life, Depression, and Limitations in the Ability to Participate in Social Roles and ActivitiesJournal of Psoriasis and Psoriatic Arthritis · 2023
15. Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment RecommendationsThe Journal of Rheumatology · 2022
16. Factors Associated with Multi-Biologic Use in Psoriasis Patients at an Academic Medical Center and Review of Biologic SurvivalJournal of Psoriasis and Psoriatic Arthritis · 2022
17. Definitions of remission in psoriasis: a systematic literature review from the National Psoriasis FoundationJournal of the European Academy of Dermatology and Venereology · 2022
18. Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriatic ArthritisDermatology and Therapy · 2022
19. Treatment Goals for Psoriasis as Measured by Patient Benefit Index: Results of a National Psoriasis Foundation SurveyAdvances in Therapy · 2022
20. Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic DiseaseJAMA Dermatology · 2022